Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asad Bashey

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Blood|October 16, 2004
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populationsHakumei Oh, Fausto R Loberiza, Mei-jie Zhang, et al.
Transplantation and Cellular Therapy|June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall SurvivalGurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.
British Journal of Haematology|June 14, 2021
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantationCarolyn M Mulroney, Muhammad Bilal Abid, Asad Bashey, et al.
Blood Advances|October 5, 2019
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancyScott R Solomon, Andrew St Martin, Nirav N Shah, et al.
Blood|March 3, 2021
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysisScott R Goldsmith, Muhammad Bilal Abid, Jeffery J Auletta, et al.
Blood|November 29, 2002
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphomaJohn E Levine, Richard E Harris, Fausto R Loberiza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTRRichard F Schlenk, Marcelo C Pasquini, Waleska S Pérez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2015
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term SurvivorsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus M Kröger, et al.
The New England Journal of Medicine|July 14, 2016
Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S Davids, Haesook T Kim, Pavan Bachireddy, et al.
Haematologica|September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMTBhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Blood|October 16, 2004
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populationsHakumei Oh, Fausto R Loberiza, Mei-jie Zhang, et al.
Transplantation and Cellular Therapy|June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall SurvivalGurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.
British Journal of Haematology|June 14, 2021
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantationCarolyn M Mulroney, Muhammad Bilal Abid, Asad Bashey, et al.
Blood Advances|October 5, 2019
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancyScott R Solomon, Andrew St Martin, Nirav N Shah, et al.
Blood|March 3, 2021
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysisScott R Goldsmith, Muhammad Bilal Abid, Jeffery J Auletta, et al.
Blood|November 29, 2002
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphomaJohn E Levine, Richard E Harris, Fausto R Loberiza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTRRichard F Schlenk, Marcelo C Pasquini, Waleska S Pérez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2015
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term SurvivorsEvgeny Klyuchnikov, Ulrike Bacher, Nicolaus M Kröger, et al.
The New England Journal of Medicine|July 14, 2016
Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S Davids, Haesook T Kim, Pavan Bachireddy, et al.
Haematologica|September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMTBhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Pageof 13